
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 0.620 | 0.620 | 0.000 |
Shares | 99.380 | 99.380 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 35.598 | 16.947 |
Price to Book | 6.623 | 2.411 |
Price to Sales | 6.744 | 1.981 |
Price to Cash Flow | 27.232 | 9.492 |
Dividend Yield | 0.734 | 3.034 |
5 Years Earnings Growth | 15.784 | 10.885 |
Name | Net % | Category Average |
---|---|---|
Technology | 29.730 | 22.488 |
Healthcare | 22.800 | 10.763 |
Consumer Cyclical | 15.860 | 12.560 |
Industrials | 13.070 | 13.318 |
Consumer Defensive | 6.330 | 10.746 |
Financial Services | 5.720 | 14.374 |
Basic Materials | 4.330 | 12.632 |
Communication Services | 2.160 | 9.694 |
Number of long holdings: 31
Number of short holdings: 0
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
NVIDIA Corp | - | 5.78 | - | - | |
Taiwan Semiconductor Manufacturing Co Ltd ADR | - | 5.53 | - | - | |
Kingspan | IE0004927939 | 5.36 | 71.35 | 0.00% | |
Microsoft Corp | - | 5.31 | - | - | |
Atlas Copco AB A | SE0011166610 | 4.57 | - | - | |
Linde PLC | IE00BZ12WP82 | 4.30 | - | - | |
Masimo Corp | - | 4.20 | - | - | |
Moncler SpA | IT0004965148 | 4.17 | 50.40 | +1.04% | |
ResMed Inc | - | 4.03 | - | - | |
L'Oreal | FR0000120321 | 3.96 | 362.55 | -0.41% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Actinver Portafolio Tactico 1 B | 4.34B | 41.00 | 4.17 | 11.16 | ||
Actinver Portafolio Tactico 3 A | 4.3B | -5.21 | 13.49 | 8.11 | ||
Actinver Portafolio Tactico 3 B | 4.3B | -6.43 | 10.57 | 5.32 | ||
Actinver Portafolio Tactico 3 E | 4.3B | -6.37 | 10.66 | 5.46 | ||
Actinver Portafolio Tactico 1 A | 4.29B | -3.75 | 7.67 | 10.95 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review